Stay updated on Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial page.

Latest updates to the Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial page
- Check5 days agoChange DetectedRevision stamp updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added. The previous government-funding operating-status notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedThe page now includes a 'Show glossary' option and a new 'Last Update Submitted that Met QC Criteria' entry with 'Revision: v3.4.0' in the metadata. Minor capitalization updates (No FEAR Act Data) and removal of older entries (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now displays Revision: v3.3.4 in the metadata/footer, replacing Revision: v3.3.3. This is an administrative update that does not alter study content or functionality.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded multiple new study locations across Florida, Illinois, Indiana, Kentucky, Michigan, Missouri, Nebraska, New Jersey, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, and Wisconsin (Revision: v3.3.3).SummaryDifference2%

Stay in the know with updates to Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial page.